Caffeinated Capital

Founded 2009
Founders Raymond Tonsing

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 71
Average round size
info
The average size of a deal this fund participated in
$37M
Portfolio companies 59
Rounds per year 5.92
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.39
Exits 6
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Software
  • SaaS
  • Financial Services
  • Information Technology
  • Internet
Summary

In 2009 was created Caffeinated Capital, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The current fund was established by Raymond Tonsing. The overall number of key employees were 2.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Caffeinated Capital, startups are often financed by Y Combinator, Raymond Tonsing, Andy Rankin. The meaningful sponsors for the fund in investment in the same round are Founders Fund, GGV Capital, Elad Gil. In the next rounds fund is usually obtained by Felicis Ventures, GGV Capital, CRV.

The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Caffeinated Capital is more than 1 billion dollars. The fund is generally included in 7-12 deals every year. Opposing the other organizations, this Caffeinated Capital works on 25 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.

The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Apps, Blockchain. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight OpenDoor Labs, Affirm, Brex.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Caffeinated Capital:
Typical Co-investors
Caffeinated Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Caffeinated Capital:

Funds with similar focus

Funds from United States, San Francisco
Funds with similar focus located in United States, San Francisco:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ookbee Thailand, Bangkok
Metallavon VC -
Tomita Pharmaceutical Japan, Kumamoto
Clarim -
Ofir Technologies -
Carmen Innovations -
Karel Electronics Turkey, Ankara
Xian Aerospace Base International Incubator China, Xian Shi
Crassets Investment China, Shanghai
Reliance Modal Ventura -
Quester United Kingdom, London
Leo Partners Investment South Korea, Seoul
Ren Quan Ventures China, Beijing
Shea Ventures United States, Walnut
NorthPort Investments United States, Northfield
Anchorage Capital Group L.L.C. United States, New York
Solar Capital Partners -
Equilibrium Capital United States, San Francisco
Snowball Effect New Zealand, Parnell
Scala Ventures Switzerland, Lugano

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Known Medicine

Biotechnology
Health Care
Life Science
Medical
1
$7M25 Aug 2021 United States, Salt Lake City

Divvy

Financial Services
Real Estate
Rental Property
1
$200M13 Aug 2021 United States, San Francisco

Polywork

Information Technology
1
$13M05 Aug 2021 United States, New York

Varda

Aerospace
Manufacturing
Product Design
1
$42M21 Jul 2021

Pathpoint

Financial Services
Insurance
InsurTech
Software
1
$30M29 Jun 2021 United States, San Francisco

Capchase

Financial Services
FinTech
Payments
SaaS
1
$125M04 Jun 2021 United States, New York

Ready

Financial Services
FinTech
Software
1
$4M31 May 2021 United States, San Francisco

Resolve

Financial Services
FinTech
n/a
$60M27 May 2021 United States, Oakland

Health Care
Medical
1
$3M25 Mar 2021 United States, San Francisco
News
Peach Finance Secures $20 Million in Series A Funding Led by Canapi Ventures
– Peach Finance raised $20m in Series A funding. – Canapi Ventures led the round with participation from existing and new investors, SciFi VC, Caffeinated Capital, Nyca Partners and Moore Specialty Credit. – The funding will support Peach’s continued expansion within the massive and growing loan management and servicing market, including through new credit product launches, customer growth initiatives and increased hiring. Peach is the first all-in-one SaaS platform addressing the full range of evolving needs of... Read more
Known Medicine Raises $7.2M in Seed Funding
– Known Medicine is a Salt Lake City, Utah-based 3D cell culture data set company. – The company raised $7.2M in seed funding. – The round was led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator, Chris Gibson and Nish Bhat. – The new investment will be used to grow the company’s proprietary 3D cell culture data set for deployment in partnership with biopharmaceutical companies and in the clinical diagnostics space. Read more

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Caffeinated Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: